- Report
- December 2023
- 82 Pages
Europe
From €2807EUR$2,950USD£2,403GBP
- Report
- April 2024
- 115 Pages
United States
From €1713EUR$1,800USD£1,466GBP
- Report
- October 2023
- 140 Pages
North America
From €4186EUR$4,400USD£3,585GBP
- Report
- February 2024
- 82 Pages
United States
From €4519EUR$4,750USD£3,870GBP
- Report
- June 2020
- 464 Pages
Global
From €4662EUR$4,900USD£3,992GBP
- Report
- March 2022
- 405 Pages
Global
From €4566EUR$4,799USD£3,910GBP
- Report
- October 2022
- 348 Pages
Indonesia, Malaysia, Singapore Indonesia, Malaysia, Singapore
From €4757EUR$5,000USD£4,073GBP
- Report
- October 2022
- 220 Pages
United States
From €4757EUR$5,000USD£4,073GBP
- Report
- July 2020
- 300 Pages
Global
From €5233EUR$5,500USD£4,481GBP
- Report
- June 2020
- 180 Pages
Global
From €5709EUR$6,000USD£4,888GBP
- Report
- December 2022
- 211 Pages
Global
From €5709EUR$6,000USD£4,888GBP
- Report
- March 2022
- 312 Pages
Global
From €6660EUR$7,000USD£5,703GBP
- Report
- March 2018
- 495 Pages
Global
From €4710EUR$4,950USD£4,033GBP
- Report
- May 2022
- 170 Pages
Middle East
From €4995EUR$5,250USD£4,277GBP
- Report
- August 2021
- 249 Pages
Global
From €4995EUR$5,250USD£4,277GBP
- Report
- October 2018
- 165 Pages
Global
From €4710EUR$4,950USD£4,033GBP
- Report
- June 2022
- 358 Pages
Global
From €3330EUR$3,500USD£2,851GBP
- Report
- June 2022
- 611 Pages
Global
From €3321EUR$3,490USD£2,843GBP
- Report
- March 2020
- 314 Pages
Global
From €2084EUR$2,190USD£1,784GBP
- Report
- January 2018
- 240 Pages
Global
From €1522EUR$1,600USD£1,303GBP
The biopsy market within the context of In Vitro Diagnostics (IVD) is a segment of the healthcare industry that focuses on the diagnosis of diseases and conditions through the analysis of biological samples. Biopsy tests are used to detect a wide range of conditions, including cancer, infections, and autoimmune diseases. The biopsy market is composed of a variety of products and services, including biopsy needles, biopsy forceps, biopsy punches, and biopsy kits. These products are used to collect tissue samples from patients for further analysis.
The biopsy market is driven by the increasing prevalence of chronic diseases, the growing demand for personalized medicine, and the development of advanced technologies. Additionally, the increasing adoption of minimally invasive procedures and the rising demand for cost-effective diagnostic solutions are expected to drive the growth of the biopsy market.
Some of the major companies in the biopsy market include Becton Dickinson, Cook Medical, Olympus Corporation, Stryker Corporation, and Hologic Inc. Show Less Read more